<DOC>
	<DOCNO>NCT00151619</DOCNO>
	<brief_summary>Patients congestive heart failure usually treat combination ACE inhibitor ( AT1 block agent ) , diuretic beta-blocker . However , patient remain symptomatic despite optimal treatment drug . In patient also coronary heart disease , nitrate calcium-channel blocker could help relieve symptom . Therefore , aim study evaluate additional benefit induced second generation calcium-channel blocker , amlodipine , patient chronic heart failure remain symptomatic despite optimal treatment .</brief_summary>
	<brief_title>Effects Amlodipine Management Chronic Heart Failure</brief_title>
	<detailed_description>In patient congestive heart failure , treatment ACE inhibitor combine digoxin diuretic show benefit morbidity mortality . However , 40 % patient persistant symptom . The rationale use calcium channel blocker patient chronic heart failure lie vasodilating action , antiischemic effect , ability reduce leave ventricular diastolic dysfunction . The objective study evaluate regional systemic hemodynamic , hormonal vascular effect tolerance stress test 3-months treatment amlodipine . Patients stable chronic heart failure ( III/IV NYHA ) treat combination enalapril , furosemide digoxin randomize receive amlodipine 5 10 mg placebo 3-months period .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Patients 18 year Chronic heart failure New York Heart Association class III IV . Ischemic dilate cardiopathy know least 3 month Systolic arterial pressure &gt; 110 mmHg treatment Stroke volume 20 40 % treatment Informed write consent History allergy one study pharmaceutical class History trouble ventricular rythm ( tachycardia , fibrillation ) acute heart failure Chronic renal , hepatic respiratory failure Diabetes Valvulopathy Myocarditis , constrictive pericarditis Life prognosis &lt; 6 month due non cardiac pathology Absence woman contraception , pregnancy , breastfeed Treatment calcium channel blocker antiarrythmics class IC Unstable patient standardize treatment Unable stress test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2005</verification_date>
	<keyword>Calcium channel blocker</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Hemodynamics</keyword>
</DOC>